U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972719) titled 'Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy' on April 30.
Brief Summary: The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
BRCA1 Mutation
BRCA2 Mutation
Intervention:
BEHAVIORAL: Experimental Arm
Participants will be randomized to SOC plus the video.
BEHAVIORAL: SOC Arm
Participants will be randomized to SOC counseling.
Recruitment Status: NOT_YET_RECRUITING
Sponsor:...